Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis

被引:45
作者
Langford, Aili, V [1 ]
Gnjidic, Danijela [1 ]
Lin, Chung-Wei Christine [2 ]
Bero, Lisa [1 ,3 ]
Penm, Jonathan [1 ]
Blyth, Fiona M. [4 ]
Schneider, Carl R. [1 ]
机构
[1] Univ Sydney, Sch Pharm, Fac Med & Hlth, Sydney, NSW 2790, Australia
[2] Univ Sydney, Inst Musculoskeletal Hlth, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia
[3] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia
[4] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
clinical practice guidelines; attitudes; healthcare quality improvement; pain; qualitative research; PEOPLE; OLDER;
D O I
10.1136/bmjqs-2020-010881
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Chronic prescription opioid use is a major international public health issue associated with significant harms, including increased risk of hospitalisation, morbidity and death. Guidance for healthcare professionals on when and how to deprescribe or reduce opioids is required. A key step for guideline development for deprescribing pharmacotherapy is to understand the perspectives of stakeholders. The aim of this study was to explore the perspectives of healthcare professional stakeholders on the challenges associated with opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines. Methods A qualitative study was undertaken with a purposive sample of healthcare professionals including prescribers, pharmacists and nurses. An initial cohort of participants was identified at the 2018 Australian Deprescribing Network annual meeting and two focus groups were conducted (n=20). Individual interviews were conducted with a further 11 healthcare professionals. Focus groups and interviews were audio-recorded and transcribed verbatim. Data underwent inductive thematic analysis using a phenomenological perspective. Results Healthcare professionals viewed opioid deprescribing as a challenge and identified several key barriers to deprescribing in clinical practice. Medication, patient, prescriber and health system level challenges were identified. Participants requested evidence-based guidance on the withdrawal of opioid therapies and suggested that prospective opioid deprescribing guidelines require a multitarget, multimodal intervention strategy that addresses patient psychosocial factors and incorporates behavioural change techniques. Conclusion Opioid deprescribing was perceived as a complex and challenging practice with continued prescribing the default behaviour. Evidence-based opioid deprescribing guidelines may be a valuable resource for clinicians to support clinical decision-making and reduce suboptimal opioid use.
引用
收藏
页码:133 / 140
页数:8
相关论文
共 35 条
[1]  
Agency for Clinical Innovation, 2019, DEPR WEAN OP GEN PRA
[2]  
[Anonymous], 2017, PAIN MAN OP EP BAL S
[3]  
Australian and New Zealand College of Anaesthetists (ANZCA), 2018, POS STAT US SLOW REL
[4]   Changing the Language of Addiction [J].
Botticelli, Michael P. ;
Koh, Howard K. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (13) :1361-1362
[5]  
Braun V., 2006, Qual Res Psychol, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
[6]   A Proactive Response to Prescription Opioid Abuse [J].
Califf, Robert M. ;
Woodcock, Janet ;
Ostroff, Stephen .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (15) :1480-1485
[7]   Drug addiction [J].
Camí, J ;
Farré, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10) :975-986
[8]  
Farrell B, 2017, CAN FAM PHYSICIAN, V63, P354
[9]   Barriers and Strategies in Guideline Implementation-A Scoping Review [J].
Fischer, Florian ;
Lange, Kerstin ;
Klose, Kristina ;
Greiner, Wolfgang ;
Kraemer, Alexander .
HEALTHCARE, 2016, 4 (03)
[10]   Universal precautions in pain medicine: A rational approach to the treatment of chronic pain [J].
Gourlay, DL ;
Heit, HA ;
Almahrezi, A .
PAIN MEDICINE, 2005, 6 (02) :107-112